Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

Circulation Research

Volumn 85, Issue 3, 1999, Pages 221-228

  Asahara, Takayuki ^a,b   Masuda, Haruchika ^a   Takahashi, Tomono ^a   Kalka, Christoph ^a   Pastore, Christopher ^a   Silver, Marcy ^a   Kearne, Marianne ^a   Magner, Meredith ^a   Isner, Jeffrey M ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Bone marrow transplantation; Endothelial progenitor cell; Flk 1; Tie 2; Vasculogenesis

Indexed keywords

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CELL CULTURE; CANCER TRANSPLANTATION; ENDOTHELIUM CELL; GENE EXPRESSION; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; LIMB ISCHEMIA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OVULATION INDUCTION; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROMOTER REGION; STEM CELL; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; TUMOR VASCULARIZATION; WOUND HEALING;

EID: 0033529618     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.85.3.221     Document Type: Article

References (44)

1. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol. 1995;11: 73-91.
2. Risau W, Sariola H, Zerwes H-G, Sasse J, Ekblom P, Kemler R, Doetschman T. Vasculogenesis and angiogenesis in embryonic stem cell-derived embryoid bodies. Development. 1988;102:471-478.
3. Flamme I, Risau W. Induction of vasculogenesis and hematopoiesis in vitro. Development. 1992;116:435-439.
4. His W. Leoithoblast und angioblast der wirbelthiere. Abhandl K S Ges Wiss Math Phys. 1900;22:171-328.
5. Weiss M, Orkin SH. In vitro differentiation of murine embryonic stem cells: new approaches to old problems. J Clin Invest. 1996;97:591-595.
6. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:965-967.
7. Shi Q, Rafii S, Wu MH-D, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MAS, Storb RF, Hammond WP. Evidence for circulating bone marrow-derived endothelial cells. Blood. 1998;92:362-367.
8. Hatzopoulos AK, Folkman J, Vasile E, Eiselen GK, Rosenberg RD. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development. 1998;125:1457-1468.
9. Springer ML, Chen AS, Kraft PE, Bednarski M, Blau HM. VEGF gene delivery to muscle: potential role of vasculogenesis in adults. Mol Cell. 1998;2:549-558.
10. Pardanaud L, Altman C, Kitos P, Dieterien-Lievre F. Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. Development. 1989;105:473-485.
11. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM. A mouse model of angiogenesis. Am J Pathol. 1998;152:1667-1679.
12. Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J, Hall SR, Hawkins HK, Berens K, Ballantyne CM. Myocardial ischemia and reperfusion: a murine model. Am J Physiol. 1995;269:H2147-H2154.
13. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu X-F, Breitman ML, Schuh AC. Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature. 1995;376:62-66.
14. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gentron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 1995;376:70-74.
15. Pereira RF, Halford KW, O'Hara MD, Leeper DB, Sokolov BP, Pollard MD, Bagasra O, Prockop DJ. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A. 1995;92:4857-4861.
16. Bassett DEL. The changes in the vascular pattern of the ovary of the albino rat during the estrous cycle. Am J Anat. 1943;73:251-278.
17. Ferrara N, Chen H, David-Smith T, Gerber HP, Nguyen TN, Peers D, Chisholm V, Hillan KJ, Schwall RH. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med. 1998;4:336-340.
18. Fong G-H, Rossant J, Gersenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 1995;376:66-70.
19. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM. Therapeutic angiogenesis: a single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J Clin Invest. 1994;93:662-670.
20. 165. Lancet. 1996;348: 370-374.
21. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 1994;89:2183-2189.
22. Pearlman JD, Hibberd MG, Chuang ML. Harada K, Lopez JJ, Gladston SR, Friedman M, Sellke FW, Simons M. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med. 1995;1:1085-1089.
23. Li J, Brown LF, Hibberd MG, Grossman JD. Morgan JP, Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol. 1996;270:H1803-H1811.
24. Schnurch H, Risau W. Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development. 1993;119:957-968.
25. Dumom DJ, Fong G-H, Fong MC, Puri G, Gradwohl G, Alitalo K, Breitman ML. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev Dyn. 1995;203:80-92.
26. Dumont DJ, Gradwohl G, Guo-Hua F, Puri MC, Gertsenstein M, Auerbach A, Breitman ML. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 1994;8:1897-1909.
27. Ferrari G, Angelis GCD, Coletta M, Paolucci E, Stomaiuolo A, Gossu G, Mavilio F. Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 1998;279:1528-1530.
28. Gospodarowicz D, Takral TK. Production of a corpus luteum angiogenic growth factor responsible for proliferation of capillaries and neovascularization of the corpus luteum. Proc Natl Acad Sci U S A. 1978;75:847-851.
29. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989;161:851-855.
30. Ferrara N, Schweigerer L, Neufeld G, Mitchell R, Gospodarowicz D. Pituitary follicular cells produce basic fibroblast growth factor. Proc Natl Acad Sci U S A. 1987;84:5773-5777.
31. Maisonpierre P, Suri C, Jones P, Bartunkova S, Wiegand S, Radziejewski C, Compton D, McClain J, Aldrich T, Papadopoulos N, Daly T, Davis S, Sato T, Yancopoulos G. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997;277:55-60.
32. Prokop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276:71-74.
33. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182-1186.
34. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353-364.
35. Folkman J. Toward an understanding of angiogenesis: search and discovery. Perspect Biol Med. 1985;29:10-36.
36. Dvorak HF. Tumors: wounds that do not heal: similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315: 1650-1659.
37. Folkman J, Klagsbrun M. Angiogenic factors. Science. 1987;235: 442-447.
38. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267:10931-10934.
39. Isner JM. The role of angiogenic cytokines in cardiovascular disease. Clin Immunol Immunopathol. 1996;80:S82-S91.
40. Ware JA, Simons M. Angiogenesis in ischemic heart disease. Nat Med. 1997;3:158-164.
41. Hatva E, Bohling T, Jaaskelainen J, Perssico MG, Haltia M, Alitalo K. Vascular growth factors and receptors in capillary hemangioblastomas and nemangiopericytomas. Am J Pathol. 1996;148:763-775.
42. Kalka C, Masuda H, Takahashi T, Li T, Asahara T. Administration of culture-expanded endothelial progenitor cells (EPC) augments therapeutic neovascularization. Circulation. 1998;97 (suppl I):I-455. Abstract.
43. Peretz D, Gitay-Goren H, Safran M, Kimmel N, Gospodarowicz D, Neufeld G. Glycosylation of vascular endothelial growth factor is not required for its mitogenic activity. Biochem Biophys Res Commun. 1992; 182:1340-1347.
44. Solovey A, Lin Y, Brown P, Choong S, Wayner E, Hebbel RP. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med. 1997;337:1582-1590.